Largest pharmaceutical companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at DKK 588.2B, ahead of Johnson & Johnson (DKK 554.7B) and Merck & Co (DKK 357.8B). Figures as of 20 Nov 2026, 06:38 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerDKK 588.2B
- Median
- DKK 4.4B
- Combined market value
- DKK 25.41T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | DKK 588.2B | DKK 1.07T | DKK 187.34 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | DKK 554.7B | DKK 4.37T | DKK 1,817.19 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 357.8B | DKK 2.23T | DKK 903.42 | 3.61% down | 45% up | ||
| 4 | Abbott LaboratoriesABT · Health Care | DKK 354.6B | DKK 1.22T | DKK 706.56 | 0.58% down | 16% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | DKK 212.6B | DKK 649.7B | DKK 6,280.91 | 2.35% down | 28% up | ||
| 6 | Eli LillyLLY · Health Care | DKK 180.5B | DKK 8.19T | DKK 9,190.83 | 2.29% down | 33% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | DKK 127B | DKK 898B | DKK 3,541.73 | 2.94% down | 27% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | DKK 125.7B | DKK 811.2B | DKK 396.85 | 2.05% down | 30% up | ||
| 9 | ViatrisVTRS · Health Care | DKK 100.1B | DKK 155B | DKK 135.23 | 1.97% down | 99% up | ||
| 10 | Royalty PharmaRPRX · Health Care | DKK 66.1B | DKK 264.9B | DKK 460.66 | 1.38% down | 79% up | ||
| 11 | United TherapeuticsUTHR · Health Care | DKK 48.3B | DKK 162B | DKK 3,803.21 | 3.16% down | 22% up | ||
| 12 | Elanco Animal HealthELAN · Health Care | DKK 44.5B | DKK 89.4B | DKK 178.83 | 1.54% down | 26% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | DKK 41.4B | DKK 80.9B | DKK 417.80 | 0.02% down | 17% up | ||
| 14 | ZoetisZTS · Health Care | DKK 22.7B | DKK 223.3B | DKK 549.56 | 5.59% down | 26% down | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | DKK 6.9B | DKK 39B | DKK 1,951.87 | 3.94% down | 50% up | ||
| 16 | Legend BiotechLEGN · Health Care | DKK 6.8B | DKK 21.2B | DKK 109.52 | 0.92% down | 41% down | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | DKK 6B | DKK 59.1B | DKK 2,114.86 | 1.87% up | 86% up | ||
| 18 | Alnylam PharmaceuticalsALNY · Health Care | DKK 5.4B | DKK 134.7B | DKK 1,005.53 | 1.06% down | 66% down | ||
| 19 | Belite BioBLTE · Health Care | DKK 5.2B | DKK 41.7B | DKK 1,027.30 | 3.33% down | 43% up | ||
| 20 | InsmedINSM · Health Care | DKK 5B | DKK 215.6B | DKK 982.67 | 20.58% up | 40% down | ||
| 21 | Spyre TherapeuticsSYRE · Health Care | DKK 4.9B | DKK 63.1B | DKK 664.12 | 3.77% down | 332% up | ||
| 22 | Summit TherapeuticsSMMT · Health Care | DKK 4.5B | DKK 57.5B | DKK 71.90 | 0.67% up | 36% down | ||
| 23 | TG TherapeuticsTGTX · Health Care | DKK 4.4B | DKK 66.7B | DKK 441.34 | 1.88% down | 117% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | DKK 4.4B | DKK 48.4B | DKK 442.02 | 4.15% down | 10% down | ||
| 25 | Cogent BiosciencesCOGT · Health Care | DKK 4.3B | DKK 32.8B | DKK 188.70 | 0.25% down | 20% down | ||
| 26 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.2B | DKK 55.1B | DKK 843.63 | 2.47% down | 51% up | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.1B | DKK 62.7B | DKK 2,698.78 | 0.34% down | 27% down | ||
| 28 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.6B | DKK 30.7B | DKK 280.05 | 0.48% down | 86% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.4B | DKK 32.5B | DKK 577.05 | 1.01% up | 108% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | DKK 3.3B | DKK 30.8B | DKK 185.16 | 0.62% down | 63% down | ||
| 31 | Oruka TherapeuticsORKA · Health Care | DKK 3.2B | DKK 45B | DKK 663.71 | 1.91% up | 255% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 3.2B | DKK 42B | DKK 296.92 | 1.25% up | 13% up | ||
| 33 | Definium TherapeuticsDFTX · Health Care | DKK 2.3B | DKK 27.5B | DKK 200.53 | 1.24% up | 168% up | ||
| 34 | ErascaERAS · Health Care | DKK 2.2B | DKK 33.9B | DKK 96.73 | 3.34% up | 395% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | DKK 2.1B | DKK 42.4B | DKK 649.70 | 3.27% up | 34% up | ||
| 36 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 946M | DKK 55.1B | DKK 794.52 | 1.88% down | 18% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | DKK 781.1M | DKK 31.5B | DKK 328.55 | 3.86% down | 45% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | DKK 600.6M | DKK 48.5B | DKK 922.95 | 1.25% up | 6% down | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | -DKK 481.6M | DKK 50.7B | DKK 145.50 | 2.24% down | 90% up | ||
| 40 | VeradermicsMANE · Health Care | -DKK 823.2M | DKK 35.7B | DKK 846.15 | 0.38% down | 231% up | ||
| 41 | PTC TherapeuticsPTCT · Health Care | -DKK 1.4B | DKK 33.1B | DKK 396.75 | 3.16% down | 21% down | ||
| 42 | CytokineticsCYTK · Health Care | -DKK 4.5B | DKK 48.8B | DKK 350.05 | 0.27% up | 19% down | ||
| 43 | BridgeBio PharmaBBIO · Health Care | -DKK 14.2B | DKK 103.6B | DKK 531.81 | 0.22% up | 21% up | ||
| 44 | AbbVieABBV · Health Care | -DKK 22.2B | DKK 3.41T | DKK 1,928.75 | 0.86% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8024 DKK).
Questions and answers
Which pharmaceutical companies in the United States rank first by net assets?
Pfizer (DKK 588.2B), Johnson & Johnson (DKK 554.7B) and Merck & Co (DKK 357.8B) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 06:38 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by net assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of DKK 25.41T as of 20 Nov 2026, 06:38 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.